雅努斯两连衣具有液体自和血液凝块抗粘合性,可满足血液静止
Qiao Yu1, Wenjie Wang2, Ningyue Deng3
1Institute for Disaster Management and Reconstruction, Sichuan University, Chengdu, 610207, China.
Advanced healthcare materials
|June 8, 2024
概括
一种新的Janus两性静血可以改善创伤患者的出血控制. 它独特的自动作和抗粘附特性确保安全,有效的伤口管理和更容易的带去除.
科学领域:
- 生物材料科学 生物材料科学
- 伤口愈合 治愈 伤口愈合
- 紧急医疗 紧急医疗
背景情况:
- 静血材料对于在创伤紧急情况下控制出血至关重要.
- 当前的血静止剂通常会粘附在伤口上,在移除后会再次造成伤害.
- 需要先进的静血带,提高疗效和患者舒适度.
研究的目的:
- 为紧急出血控制开发一种有效的雅努斯两性静血包.
- 为了解决传统血静止器的局限性,特别是伤口粘附性.
- 为了增强静血性能,并促进安全地去除连衣.
主要方法:
- 用一层疏水性纤维 (聚乳酸/甲基) 和一层疏水性水凝 (聚乙烯醇,甲基,Ca2+,高) 制造复合敷料.
- 研究了血清排水和凝结因子度的"自"机制.
- 评估了连接剂的静血效果,抗粘附性质和生物相容性.
主要成果:
- 雅努斯的敷料显示出单向的血清排水,使血小板和红细胞集中.
- 离子 (Ca2+) 从水凝层扩散,激活血小板和凝血级联.
- 纤维层表现出抗粘附特性,允许轻松安全地去除包裹,而不会破坏凝块.
结论:
- 开发的Janus两位神经的血静止 (Fiber@Gel/Ca2+/KL) 显示出控制出血的巨大潜力.
- 它的自和抗粘附特性比现有的血静止器具有优势.
- 这种新的包裹预计将成为创伤护理中临床血静的安全和有效选择.
相关概念视频
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
Coagulation
6.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.2K
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K


